Both XELIRI And TEGAFIRI Togetherwith Bevacizumab are Effective for Recurrent or Metastatic Colorectal Cancer: A Real-Life Experience

1.1. Objective: To evaluate a surgeon?s experience of combination chemotherapy comprising different regimens of fluorouracil with or without irinotecan together with bevacizumab with respect to response rate for patients with recurrent or metastatic colorectal cancer.